BIOFvs its industry peers
A metric-by-metric comparison of BIOF against SIC 2860 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOFThis | — | — | — | — | — | -102.6%#6 | -6191.9%#5 | — | — | — | — | — |
| LNZAW | $261783#4 | 0.0x#1 | 0.0x#1 | 0.0x#1 | 12.6%#1 | 64.4%#1 | -141.7%#3 | -18.8%#3 | -35.2%#1 | — | — | — |
| BAK | $946M#2 | — | — | — | — | — | — | — | — | — | -38.5%#2 | — |
| CLNV | — | — | — | — | -10.2%#3 | 1.9%#3 | -3163.5%#4 | — | — | 5#1 | — | — |
| CNEY | $3M#3 | — | 0.0x#2 | 0.1x#2 | -30.2%#4 | 20.6%#2 | -30.9%#2 | -10.9%#2 | — | 5#1 | -77.6%#3 | — |
| MEOH | $5.0B#1 | — | 2.0x#3 | 1.4x#3 | -3.5%#2 | -42.1%#5 | 12.0%#1 | 5.9%#1 | — | — | 65.5%#1 | 1.1%#1 |
| QGAI | — | — | — | — | — | -11.6%#4 | — | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2860). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice